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The Relationships between Macular Pigment Optical
Density and Its Constituent Carotenoids in Diet
and Serum
John M. Nolan,1 Jim Stack,2 Eamonn O’Connell,3 and Stephen Beatty1,3
PURPOSE. Lutein (L) and zeaxanthin (Z) are two dietary carote-
noids that accumulate at the macula, where they are collec-
tively known as macular pigment (MP). There is a biologically
plausible rationale, with some supporting evidence, that MP
may protect against age-related maculopathy (ARM). This study
was undertaken to investigate the relationship between dietary
intake of L and Z, serum concentrations of these carotenoids,
and MP optical density in 828 healthy Irish subjects.
METHODS. Dietary intake of L and Z was assessed with a vali-
dated food-frequency questionnaire, and serum concentrations
of these carotenoids were quantified by high-performance liq-
uid chromatography. MP optical density was measured psycho-
physically, using heterochromatic flicker photometry. Demo-
graphic data, lifestyle data, and general health status, were also
recorded by questionnaire, with particular attention directed
toward risk-factors (established and putative) for ARM.
RESULTS. The relationships between MP optical density, serum
concentrations of L (and Z), and dietary intake of L (and Z)
were positive and statistically significant when analyzed for the
entire study group (r  0.136–0.303; P  0.01 for all). Sub-
jects with a clinically confirmed family history of ARM, current
heavy cigarette smokers, subjects aged more than 53 years, and
subjects with a body mass index (BMI) 27, did not demon-
strate a positive and significant relationship between MP opti-
cal density and serum concentrations of Z (r  0.041, r 
0.001, r  0.074 and r  0.082, respectively; P  0.05 for all).
However, there was a positive and significant relationship
between MP optical density and serum concentrations of L in
the presence of all these risk factors (r  0.165 to 0.257),
except for current heavy smokers (r  0.042; P  0.05).
CONCLUSIONS. For subjects at increased risk of ARM (e.g., sub-
jects with a clinically confirmed family history of ARM, current
heavy cigarette smokers, subjects aged  53 years and subjects
with a BMI  27) retinal capture and/or retinal stabilization of
Z appears to be compromised, whereas retinal uptake and/or
stabilization of L appears to be compromised in current heavy
smokers only. Given the lack of MP in association with risk for
ARM, the findings indicate that a retina predisposed to this
condition may have an impaired ability to accumulate circulat-
ing Z. (Invest Ophthalmol Vis Sci. 2007;48:571–582) DOI:
10.1167/iovs.06-0864
Age-related macular degeneration (AMD), the late stage ofage-related maculopathy (ARM), is the leading cause of
blindness in individuals more than 65 years of age in the
Western World.1,2 The etiological mechanisms underlying
ARM continue to elude, but there is a growing body of evi-
dence implicating oxidative stress and/or cumulative blue light
damage in the process.3 The carotenoids lutein (L) and zeax-
anthin (Z), to the exclusion of all other carotenoids, are con-
centrated in the macula, where they are collectively referred to
as macular pigment (MP).
MP is a blue-light filter at a prereceptorial level,4 and dem-
onstrates powerful antioxidant properties.5 Consequently, it is
believed that MP may protect against macular diseases attrib-
utable to oxidative stress, most notably ARM. The hypothe-
sized protective effect of MP for ARM is rendered all the more
provocative by its dietary origins.
Existing evidence in support of the view that MP protects
against ARM is dominated by cross-sectional and epidemiologic
reports. In brief, this evidence refers to parallels between risk
for ARM and a relative lack of L and/or Z in the diet and/or
serum and/or macula (SanGiovanni JP et al. IOVS 2004;45:
ARVO E-Abstract 2242).6,7
Any protective effect of MP for ARM is premised on its
defense against chronic and cumulative oxidative and/or pho-
tochemical damage, and, as such, would need to be exerted
over a long period and decades before the onset of disease.3
Given that a positive and significant relationship between MP
and its constituent carotenoids in the diet and in the serum has
been consistently demonstrated in healthy subjects8–14 and
that a relative lack of MP has been reported in association with
certain risk-factors for ARM (SanGiovanni JP et al. IOVS 2004;
45:ARVO E-Abstract 2242),6,7 it would seem logical to investi-
gate whether the relationship between dietary and serum lev-
els of these carotenoids, or whether the relationship between
serum concentrations of L (and/or Z) and MP, is influenced by
these risk-factors in young and middle-aged subjects. In other
words, and for example, is tobacco use (an established risk-
factor for ARM) associated with an attenuated relationship
between serum levels of L and MP optical density? And if so,
can the data indicate whether such a finding represents com-
promised retinal capture of circulating carotenoids among
smokers or an altered stabilization/utilization of this xantho-
phyll within the retina of those who consume tobacco? To
date, the influence of risk factors for ARM on these relation-
ships has not been investigated, with the exception of the
influence of sex.15 However, that study reported the concen-
trations of L and Z collectively rather than individually.
The present study was designed to investigate the relation-
ship between dietary intake of L and Z, serum concentrations
of these carotenoids, and MP optical density, and to relate the
findings to risk factors for ARM (both putative and established),
in 828 healthy Irish subjects aged 20 to 60 years.
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METHODS
Subjects
Eight hundred twenty-eight healthy subjects from an Irish population
were enrolled to participate in the study, which was authorized by the
Research Ethics Committee of the Waterford Institute of Technology.
Informed consent was obtained from each subject, and the experimen-
tal procedures adhered to the tenets of the Declaration of Helsinki. The
inclusion criteria were white race and age between 20 and 60 years,
and exclusion criteria comprised any ocular disease, visual acuity less
than 6/18 in both eyes, or pregnancy.
Subjects were recruited by one of two means. The majority of
subjects were recruited as a result of posters, newsletters, and word of
mouth in the local community (group 1: n  646). Also, patients
attending the Department of Ophthalmology at Waterford Regional
Hospital who had ARM (early and/or late) were encouraged to invite
their offspring to participate (group 2: n  182). For a subject re-
cruited by posters and/or word of mouth who thought he or she had
a direct family history of ARM (offspring of ARM sufferers), the medical
records for that subject’s appropriate parent were examined by a
trained ophthalmologist, and if there was a positive family history of
ARM, confirmatory documentation was secured, and that subject was
placed into the group referred to as having a clinically confirmed family
history of ARM. Of the 828 subjects who were recruited in total, we
were unable to obtain MP measurements in 28 of these (coefficient of
variation [CoV] 20%; n  20; and visual acuity 6/18 in both eyes;
n  8). In addition, we failed to obtain dietary data from 2 individuals
and serum data from 10 individuals. Also, demographic data from two
individuals was misplaced.
Personal Details Questionnaire
Demographic data, lifestyle data, and general health status, were re-
corded by questionnaire, with particular attention directed toward risk
factors (established and putative) for ARM. The risk factors we inves-
tigated included sex; family history of ARM (subjects with a positive
family history of ARM had to have documented proof from the clinician
who diagnosed the findings); cigarette smoking status (nonsmokers,
current light smokers [20 cigarettes per day], current heavy smokers
[20 cigarettes per day]); age; body mass index (BMI; calculated as
kg/m2).
Dietary Analysis
A self-administered, semiquantitative food-frequency questionnaire
(FFQ) developed by the Scottish Collaborative Group was used for
dietary analysis. This previously validated FFQ16,17 has been described
in more detail elsewhere.12 The questionnaire was designed to esti-
mate a subject’s normal diet over the previous 2 to 3 months, which
included 166 commonly eaten food types or drink, grouped into 19
selections. The questionnaire was completed by the volunteer in the
presence of the primary investigator (JN), and took between 25 and 35
minutes to complete.
The FFQs were scanned and verified by a trained dietary data coder
using optical recognition software (Teleform Version 7; Cardiff Soft-
ware, Vista, CA) at the Medical Research Council Human Nutrition
Research (Cambridge, UK). Nutrient analysis was conducted using the
Oracle Relational Database Management System (ver. 7; Redwood
Shores, CA).18 Dietary intake of L and Z was calculated using food
composition data from UK, European, and U.S. data sources,19,20 using
standard principles or criteria for the matching of food items and
standardized recipes or manufacturer’s ingredient information where
necessary.21–23
Of the 826 dietary questionnaires completed and analyzed, 72 were
considered unreliable because they suggested levels of energy intake
that were deemed physiologically unlikely (outside the ranges 800–
3500 kcal/d for women or 1000–4000K cal/d for men).24 This was
somewhat surprising, given the close inspection, and frequent ques-
tioning performed by the investigator during the questionnaire pro-
cess. However, removing these data from our analysis seemed to have
no impact on our findings, and therefore we decided to include the
data in our main analysis.
In addition to the absolute dietary values (milligrams per day)
obtained for L and Z, we calculated nutrient density (milligrams per
kilocalorie) and energy-adjusted (by residuals method) values of L and
Z. These techniques have been described in Willet’s Nutritional Epi-
demiology.24
Serum Analysis
Blood samples (6–8 mL) were collected from all subjects on the same
day as the dietary and MP optical density analysis. Serum was separated
from blood by centrifugation at 5000 rpm for 10 minutes and then
aliquoted into three light-sensitive microcentrifuge tubes and stored at
70°C until time of analysis. Duplicate extractions were performed for
each serum sample. A 0.4-mL aliquot of serum was pipetted into a
light-sensitive microcentrifuge tubes (2 mL total capacity). Ethanol
(0.30 mL) containing 0.25 g/L butyrated hydroxytoluene (BHT) and
internal standard (tocopherol acetate) was added to each tube. Hep-
tane (0.5 mL) was then added, and samples were vortexed vigorously
for 1 minute followed by centrifugation at 2000 rpm for 5 minutes
(MSC Micro Centaur; Davison & Hardy Ltd., Belfast, UK). The resultant
heptane layer was retained and transferred to a second labeled light-
sensitive microcentrifuge tube, and a second heptane extraction was
performed. The combined heptane layers were immediately evapo-
rated to dryness under nitrogen. These dried samples were reconsti-
tuted in methanol (200 L), and 150 L was injected for high-perfor-
mance liquid chromatography (HPLC) analysis.
We used an HPLC system (Hewlett-Packard HP 1090 LC; Agilent,
Dublin, Ireland) with photodiode array detection. A 5-m analytical/
preparative 4.6  250-mm specialized reversed-phase column (201TP;
Vydac, Hesperia, CA) was used with an in-line guard column. The
mobile phase consisted of 97% methanol and 3% tetrahydrofuran. The
flow rate was 1 mL/min, and the total run time was 15 minutes. All
carotenoid peaks were integrated and quantified (Chem Station soft-
ware; Agilent).
DSM Nutritional Products (Basel, Switzerland) provided the L and Z
standards that were used to generate standard curves for quantification
of these carotenoids. This assay was validated against the National
Institute of Standards and Technology (NIST) Standard before analysis.
MP Optical Density Measurement
MP was measured psychophysically (Maculometer, developed by John
Mellerio; University of Westminster, London, UK). This device utilizes
the principle of heterochromatic flicker photometry (HFP), a tech-
nique that has been described in more detail elsewhere.25,26 The
Maculometer has been validated against motion photometry in normal
subjects.26
The concentration of MP peaks at the center of the fovea and is
optically undetectable at an eccentricity of 5°.4 In a test field that
alternates between blue light (470 nm, maximum MP absorption is at
460 nm) and green light (530 nm, not absorbed by MP), the luminance
of the blue is varied until there is no or minimal flicker, which means
the lights are isoluminant. Isoluminance matches are made with the
test field at 0° (foveal) eccentricity and at 5.5° (parafoveal) eccentric-
ity, so the logarithm of the ratio of the blue luminances in the fovea to
that in the parafovea gives the MP optical density.
The flicker frequencies were fixed at 18 Hz for the foveal target and
13 Hz for the parafoveal target. The inability to customize flicker
frequency for each subject is a limitation of the current device, as it
may lead to increased uncertainty of the match endpoint. Subjects
were allowed to make two or three trial minimum flicker matches
before measurements were recorded. Six foveal readings were ob-
tained, followed by six parafoveal readings.
Statistical Analysis
Commercial statistical software (SPSS; ver. 11, SPSS, Chicago, IL, and
Statistica, ver. 7, StatSoft, Tulsa, OK) were used for analysis. Our main
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statistical methods included Pearson correlation testing, partial corre-
lation testing, and one-way analysis of covariance (ANCOVA). Signifi-
cance was set at the standard P  0.05.
We performed power analyses for comparing subgroups (e.g.,
male/female, non–cigarette smokers, light cigarette smokers, and
heavy cigarette smokers) for each of the outcome variables of interest:
serum L, serum Z, and MP optical density. In each case, the difference
we sought to detect was 30% of the overall mean for that outcome
variable. In all but one case, the subgroup sizes were adequate to
achieve statistical power of 0.90 or better (5% level of significance,
two-tailed tests). The exception was the heavy cigarette-smoking sub-
group, which had n  46 subjects but would have required n  86
subjects for 90% power for serum Z. However, given the known
dose–response relationship between cigarette smoking and MP lev-
els,27 we feel we can justify investigating this important and interesting
subgroup.
RESULTS
For this study, we report on right-eye MP optical density.
However, for some subjects (15 of the total, 1.8%), only left-eye
MP optical density was measured (as the right eye’s visual
acuity was 6/18 and therefore did not fit the required criteria
for testing). For these subjects, we report the left-eye MP
optical density.
There was a positive and significant relationship between
MP optical density and each of its constituent carotenoids in
the serum and in the diet (for absolute, energy-adjusted, and
nutrient densities). Also, there was a positive and significant
relationship between serum concentrations of L (and Z) and
dietary intake (whether absolute, energy-adjusted, or nutrient
density) and its respective carotenoid for the study group (n 
828; Pearson correlation: r  0.136–0.303; P  0.01, for all);
Table 1. We also analyzed these relationships after removing
subjects whose dietary energy intake was deemed unrealistic
(see the Methods section; n  754; Table 2), but this measure
did not alter the strength or significance of the observed
relationships, and we therefore elected to conduct the remain-
der of our analyses for the entire study group (n  828).
The Relationship between Dietary L (and Z) and
Serum L (and Z)
The relationship between dietary intake of L and Z (absolute,
energy-adjusted and nutrient densities) and serum concentra-
tions of the respective carotenoids were positive and statisti-
cally significant (Table 1). The strength of the relationships
between absolute dietary intake of L (and Z) (milligrams per
day) and serum L (and Z) (micrograms per milliliter) were
slightly altered after adjusting for age, sex, family history status,
smoking habits, dietary fat intake and BMI (partial correlation:
r  0.309, P  0.01 and r  0.250, P  0.01, respectively).
Sex. The relationships between serum levels of L and Z and
dietary intake (whether absolute, energy-adjusted, or nutrient
































Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.963* 1
Nutrient density of dietary L 0.848* 0.928* 1
Serum L (g/mL) 0.280* 0.303* 0.299* 1
Absolute dietary Z (mg/day) 0.697* 0.609* 0.479* 0.169* 1
Energy-adjusted dietary Z 0.664* 0.668* 0.603* 0.206* 0.912* 1
Nutrient density of dietary Z 0.585* 0.643* 0.677* 0.231* 0.805* 0.939* 1
Serum Z (g/mL) 0.160* 0.166* 0.146* 0.462* 0.237* 0.260* 0.259* 1
MP optical density 0.208* 0.182* 0.136* 0.181* 0.218* 0.184* 0.166* 0.166* 1
Bold font indicates relationships of major interest n  828.
* Correlation is significant at the 0.01 level (Pearson correlation: two-tailed).
TABLE 2. Pearson Correlation Matrix Showing Relationships between the Study Parameters for the Entire Study Group after Removing Subjects




































Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.984* 1
Nutrient density of dietary L 0.889* 0.938* 1
Serum L (g/mL) 0.286* 0.301* 0.300* 1
Absolute dietary Z (mg/day) 0.682* 0.637* 0.529* 0.189* 1
Energy-adjusted dietary Z 0.658* 0.637* 0.615* 0.216* 0.953* 1
Nutrient density of dietary Z 0.608* 0.669* 0.678* 0.238* 0.862* 0.951* 1
Serum Z (g/mL) 0.150* 0.645* 0.143* 0.455* 0.249* 0.254* 0.258* 1
MP optical density 0.198* 0.153* 0.137* 0.170* 0.203* 0.175* 0.154* 0.160* 1
Bold font indicates relationships of major interest. n  754.
* Correlation is significant at the 0.01 level (Pearson correlation: two-tailed).
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density) of the respective carotenoids remained positive and sig-
nificant when the data were analyzed separately for the men (n 
288, 35%) and women (n  538, 65%; Table 3). After controlling
for absolute dietary intake of L, the adjusted group mean for
serum L was significantly higher in the women than in the men
(ANCOVA, P  0.048; Fig. 1), whereas the adjusted group mean
for serum Z was statistically similar for the two sexes (ANCOVA,
P  0.05; Fig. 2). However, when we controlled for other vari-
ables, in addition to dietary L (e.g., age, BMI) any differences in
serum L between males and females were no longer significant.
The observed significant difference for gender displayed in Figure
1 is most likely attributable therefore to confounding variables
such as cigarette smoking and BMI.
Family History Status. The respective relationships be-
tween serum concentrations of L and Z and dietary intake
(whether absolute, energy-adjusted, or nutrient density) of these
carotenoids remained positive and significant when the data were
analyzed separately for subjects with (n  182, 22%) and without
(n  644, 78%) a clinically confirmed family history of ARM
(Table 4). However, after controlling for absolute dietary intake of
L, the adjusted group mean for serum L was significantly higher
for offspring of those with ARM than for subjects without such a
family history (ANCOVA, P  0.01; Fig. 1), whereas the adjusted
group mean for serum Z was statistically similar for these sub-
groups (ANCOVA, P  0.05; Fig. 2).
Cigarette Smoking. Of the 826 subjects with smoking
information available, 660 (80%) were nonsmokers, 120
(14.5%) smoked 20 cigarettes per day, and 46 (5.5%) smoked
20 cigarettes each day. The relationships between serum
concentrations of L and Z and dietary intake (whether abso-
lute, energy-adjusted or nutrient density) of the respective
carotenoids remained positive and significant when the data
were analyzed separately for nonsmokers and current light
smokers (20 cigarettes per day; Table 5).
There was a positive and significant relationship between
dietary Z and serum Z for current heavy smokers (20 ciga-
rettes per day, n  46, 5.5%), whereas dietary L was not
significantly related to serum L in this group (Table 5). Also, the
mean adjusted serum L concentration (controlling for absolute
dietary intake of L) was significantly higher for nonsmokers
when compared to either light or heavy current smokers (AN-
COVA, P  0.01; Fig. 1). The adjusted group mean for serum
Z (controlling for absolute dietary intake of this carotenoid)
was lower for heavy current smokers when compared with




































Men (n  288)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.937* 1
Nutrient density of dietary L 0.871* 0.950* 1
Serum L (g/mL) 0.201* 0.300* 0.263* 1
Absolute dietary Z (mg/day) 0.651* 0.554* 0.521* 0.136* 1
Energy-adjusted dietary Z 0.560* 0.598* 0.586* 0.147* 0.926* 1
Nutrient density of dietary Z 0.464* 0.529* 0.578* 0.133* 0.846* 0.950* 1
Serum Z (g/mL) 0.201* 0.217* 0.178* 0.448* 0.293* 0.319* 0.295* 1
MP optical density 0.261* 0.234* 0.194* 0.195* 0.236* 0.206* 0.165* 0.164* 1
Women (n  538)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.955* 1
Nutrient density of dietary L 0.854* 0.938* 1
Serum L (g/mL) 0.271* 0.292* 0.299* 1
Absolute dietary Z (mg/day) 0.718* 0.602* 0.476* 0.179* 1
Energy-adjusted dietary Z 0.658* 0.688* 0.624* 0.219* 0.874* 1
Nutrient density of dietary Z 0.633* 0.681* 0.699* 0.255* 0.797* 0.946* 1
Serum Z (g/mL) 0.139* 0.139* 0.133* 0.449* 0.211* 0.230* 0.241* 1
MP optical density 0.207* 0.196* 0.167* 0.195* 0.221* 0.217* 0.205* 0.176* 1
Bold font indicates relationships of major interest.
* Correlation is significant at the 0.01 level (Pearson correlation: two-tailed).
FIGURE 1. Comparative representation of mean serum lutein concen-
trations, adjusted for differences in absolute dietary intake of lutein,
with respect to variables relevant to risk for age-related maculopathy
(ANCOVA); vertical bars denote  1.96 SE. M, male; F, female; FH,
subjects with no known family history of ARM; FH, subjects with a
clinically confirmed family history of ARM; NS, nonsmokers; LCS, light
current smokers (20 cigarettes per day); HCS, heavy current smokers
(20 cigarettes per day); A1, subjects aged 31 years; A2, subjects
aged between 31 and 53 years; A3, subjects aged 53 years; B1, BMI 
23; B2, BMI between 23 and 27; B3, BMI  27.
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light current smokers or nonsmokers, but the differences were
not statistically significant (ANCOVA, P  0.05; Fig. 2).
Age. We investigated the relationships between serum con-
centrations of L and Z and dietary intake (absolute, energy-
adjusted, and nutrient densities) of the respective carotenoids,
and found the relationships to be of equal significance for
subjects aged 31 years, between 31 and 53 years, and 53
years (Table 6). Subjects in the upper age tertile (53 years)
had a significantly higher mean adjusted serum L concentration
(controlling for absolute dietary intake of L) than did subjects
in the middle (aged 31–53 years) and lower (31 years) age
tertiles (ANCOVA, P  0.01; Fig. 1). In contrast, subjects in the
lower age tertile had a significantly higher mean adjusted
serum Z concentration (controlling for absolute dietary intake
of Z) than did subjects in the middle and higher age tertiles
(ANCOVA, P  0.01; Fig. 2).
Body Mass Index. The relationships between serum con-
centration of L and Z and dietary intake (absolute, energy-ad-
justed, and nutrient density) of the respective carotenoids were
positive and significant for subjects with a BMI of 23, between
23 and 27, and 27 (Table 7). However, subjects with a BMI of
23 had significantly higher adjusted mean serum L (and Z;
having controlled for absolute dietary intake of these carotenoids
separately and respectively for these analyses) than subjects in the
middle and upper BMI tertiles (BMI  23–27 and BMI  27,
respectively; ANCOVA, P  0.01, for all; Figs. 1, 2).
The Relationship between Serum L (and Z) and
MP Optical Density
The relationships between MP optical density and serum con-
centrations of each of its constituent carotenoids was positive
and significant (Table 1). The strength of the relationship
between serum L and MP optical density was improved after
adjusting for age, sex, family history, smoking status, and ab-
solute dietary intake of L (partial correlation: r  0.232, P 
0.01), whereas the strength of the relationship between serum
Z and MP optical density was reduced after controlling for the
FIGURE 2. Comparative representation of mean serum zeaxanthin
concentrations, adjusted for differences in absolute dietary intake of
zeaxanthin, with respect to variables relevant to risk for age-related
maculopathy (ANCOVA); vertical bars denote  1.96 SE. Abbrevia-
tions are as in Figure 1.
TABLE 4. Pearson Correlation Matrix Showing Relationships between the Study Parameters, Analyzed Separately for Subjects with and without




































No known family history of ARM
(n  644)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.962* 1
Nutrient density of dietary L 0.861* 0.944* 1
Serum L (g/mL) 0.239* 0.251* 0.241* 1
Absolute dietary Z (mg/day) 0.684* 0.595* 0.473* 0.154* 1
Energy-adjusted dietary Z 0.619* 0.642* 0.584* 0.169* 0.916* 1
Nutrient density of dietary Z 0.538* 0.592* 0.604* 0.182* 0.821* 0.949* 1
Serum Z (g/mL) 0.141* 0.141* 0.118* 0.492* 0.241* 0.256* 0.259* 1
MP optical density 0.230* 0.199* 0.174* 0.210* 0.228* 0.186* 0.174* 0.209* 1
Clinically confirmed family history
of ARM (n  182)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.996* 1
Nutrient density of dietary L 0.842* 0.916* 1
Serum L (g/mL) 0.364* 0.413* 0.394* 1
Absolute dietary Z (mg/day) 0.748* 0.660* 0.526* 0.210* 1
Energy-adjusted dietary Z 0.723* 0.751* 0.681* 0.308* 0.900* 1
Nutrient density of dietary Z 0.708* 0.769* 0.836* 0.344* 0.764* 0.916* 1
Serum Z (g/mL) 0.231* 0.260* 0.242* 0.377* 0.216* 0.279* 0.266* 1
MP optical density 0.240* 0.221* 0.149† 0.257* 0.228* 0.205* 0.167† 0.041‡ 1
Bold font indicates relationships of major interest.
* Correlation is significant at the 0.01 level (Pearson correlation: two-tailed).
† Correlation is significant at the 0.05 level (Pearson correlation: two-tailed).
‡ Nonsignificant relationships.
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same variables (and replacing absolute dietary intake of L with
that of Z; partial correlation: r  0.082, P  0.025).
Sex. The relationship between MP optical density and se-
rum concentrations of L (and Z) remained positive and statis-
tically significant when the data were analyzed separately for
the men and women (Table 3). However, after adjustment for
serum L (and Z, respectively), the adjusted group mean for MP
optical density was significantly higher in the men than in the
women (ANCOVA, P  0.01, for both; Figs. 3, 4).
Family History. The relationship between MP optical den-
sity and serum concentrations of L remained positive and
significant for subjects with and without a clinically confirmed
family history of ARM (Table 4), on separate analysis of the data
for these two subgroups. However, there was no statistically
demonstrable relationship between MP optical density and
serum concentrations of Z in subjects who had a clinically
confirmed family history of ARM, whereas a positive and sig-
nificant relationship between MP optical density and serum
levels of Z was demonstrable in subjects who reported having
no known family history of this condition (Table 4, Fig. 5).
Also, after controlling for serum L (and separately for serum Z),
the adjusted group mean for MP optical density was significantly
higher for subjects with no known family history of ARM when
compared to subjects with a clinically confirmed family history of
disease (ANCOVA, P  0.01, for both; Figs. 3, 4).
Cigarette Smoking. The relationship between MP optical
density and serum concentrations of L and Z remained positive
and significant for nonsmokers and for light current smokers,
when the data were analyzed separately for these two sub-
groups (Table 5; Figs. 6, 7). However, there was no statistically
demonstrable relationship between MP optical density and
serum concentrations of L or Z among heavy current smokers
(Table 5; Figs. 6, 7). Also, mean adjusted MP optical density
(controlling for serum L and Z, respectively) was significantly
lower for current heavy smokers when compared to either
current light smokers or to nonsmokers (ANCOVA, P  0.01;
Figs. 3, 4).
Age. We investigated the relationships between MP optical
density and serum concentrations of L (and Z) for subjects aged
31 years, between 31 and 53 years, and 53 years (Table 6).
There was no statistically demonstrable relationship between
serum concentrations of Z and MP optical density in subjects
aged 53 years (r  0.074, P  0.05), in contrast to relation-
ships between serum concentration of this carotenoid and MP
optical density in subjects aged 31 years and in those aged
between 31 and 53 years, which were positive and significant
(r  0.197 and r  0.137, respectively; P  0.05, for both).
Also, subjects in the upper age tertile (53 years) had a
statistically significant lower mean adjusted MP optical density
(controlling for serum L and Z, respectively) than did subjects
in the middle (aged 31–53 years) and lower (31 years) age
tertiles (ANCOVA, P  0.01; Figs. 3, 4).
Body Mass Index. There was no statistically demonstrable
relationship between MP optical density and serum concentra-
tions of Z in subjects with BMI  27 (r  0.082, P  0.05), in
contrast with the positive and significant relationships seen in
subjects with a BMI  23 and those with BMI between 23 and
27 (r  0.230 and r  0.194, respectively; P  0.01, for both;
Table 7). The relationship between MP optical density and
serum concentrations of L was positive and significant, irre-




































Nonsmokers (n  660)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.966* 1
Nutrient density of dietary L 0.858* 0.932* 1
Serum L (g/mL) 0.265* 0.283* 0.282* 1
Absolute dietary Z (mg/day) 0.681* 0.595* 0.482* 0.173* 1
Energy-adjusted dietary Z 0.634* 0.658* 0.606* 0.205* 0.911* 1
Nutrient density of dietary Z 0.585* 0.637* 0.677* 0.231* 0.813* 0.944* 1
Serum Z (g/mL) 0.103* 0.108* 0.103* 0.437* 0.218* 0.241* 0.248* 1
MP optical density 0.200* 0.178* 0.145* 0.165* 0.211* 0.182* 0.167* 0.165* 1
Current light smokers 20 cigarettes
per day (n  120)
Energy-adjusted dietary L 0.958* 1
Nutrient density of dietary L 0.896* 0.912* 1
Serum L (g/mL) 0.431* 0.488* 0.488* 1
Absolute dietary Z (mg/day) 0.756* 0.665* 0.477* 0.211* 1
Energy-adjusted dietary Z 0.679* 0.701* 0.595* 0.268* 0.920* 1
Nutrient density of dietary Z 0.554* 0.628* 0.653* 0.293* 0.770* 0.920* 1
Serum Z (g/mL) 0.406* 0.426* 0.385* 0.501* 0.300* 0.320* 0.297* 1
MP optical density 0.323* 0.311* 0.188† 0.224* 0.304* 0.294* 0.226* 0.194† 1
Current heavy smokers 20
cigarettes per day (n  46)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.941* 1
Nutrient density of dietary L 0.862* 0.961* 1
Serum L (g/mL) 0.154‡ 0.153‡ 0.154‡ 1
Absolute dietary Z (mg/day) 0.766* 0.677* 0.569* 0.085 1
Energy-adjusted dietary Z 0.678* 0.745* 0.688* 0.079 0.897* 1
Nutrient density of dietary Z 0.704* 0.289* 0.752* 0.101 0.873* 0.983* 1
Serum Z (g/mL) 0.275* 0.426* 0.263* 0.674* 0.291* 0.313* 0.308* 1
MP optical density 0.019‡ 0.134‡ 0.165‡ 0.042‡ 0.094‡ 0.104‡ 0.138‡ 0.001‡ 1
Symbols and significances are as described in Table 4.
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spective of BMI status (Table 7). Mean adjusted MP optical
density (controlling for serum L and Z, respectively) was sta-
tistically comparable in the lower (BMI  23), middle (BMI 
23–27), and upper (BMI  27) BMI tertiles (ANCOVA, P 
0.05, for all; Figs. 3, 4).
DISCUSSION
This study was specifically designed to report on the relation-
ships between dietary intake of L and Z, serum concentrations
of L and Z, and MP optical density, and to relate the findings to
risk for ARM in 828 healthy Irish subjects aged 20 to 60 years.
Of the eight published observational studies that have ex-
amined the relationship between dietary antioxidants and risk
for ARM, four have found a protective effect associated with a
high intake of carotenoids.7,28–35 Also, a recent report by the
Age-Related Eye Disease Study group has shown that a higher
dietary intake of L and Z is associated with a decreased likeli-
hood of the development of advanced ARM (SanGiovanni JP et
al. IOVS 2004;45:ARVO E-Abstract 2242).
Mean daily intake of L and Z combined, varies from 0.8 mg
to 4 mg per day, depending on the population studied and the
method of dietary assessment used.36,37 Further, daily intake of
L has been shown to vary widely among individuals, as illus-
trated by a standard deviation of 2.45 mg/d in a recently
published study.38 In the 826 volunteers who completed FFQs
in our study, mean dietary intake (SD) of L and Z was 1.399 
0.79 mg/d and 0.199  0.117 mg/d, respectively. These values
are comparable with those obtained by previous investigators
(using similar dietary assessment techniques) in similar age
groups.10,11,27,39–42
Most previous studies in which the relationship between
serum concentrations of L (and Z) and risk for ARM have been
examined, have reported the concentrations of these two caro-
tenoids collectively rather than individually.6,7,43–49 Of these,
only one found a significant association between low serum
concentrations of L and Z (combined) and risk for ARM.46
Recently, however, Gale et al.6 investigated the relationship
between serum L and Z (separately) and risk for ARM and
found that ARM was associated with a relative lack of serum Z
(but not L). It is possible that the analysis of serum L and Z in
a collective fashion in those previous studies, rather than in-
vestigating these carotenoids separately, had masked the rela-
tive importance of serum Z concentrations. In our study, mean
serum levels (SD) of L and Z were 0.087  0.042 g/mL and
0.026  0.016 g/mL, respectively, which are consistent with
those obtained by previous investigators for similar age
groups.10,47,50–52
Of the nine observational studies analyzing the relationship
between dietary intake of L and Z and serum concentrations of
these carotenoids, all have demonstrated significant and positive
relationships (r  0.21–0.74; P  0.05 for all).10–13,15,40–42,53
The largest of these studies included 2786 subjects, and found
that every 10% increase in estimated dietary intake of L and Z was
associated with a 2.4% increase in serum L concentration.16 Sim-
ilarly, we found a positive and significant relationship between
the absolute dietary intake of L and Z, and serum concentrations
of the respective carotenoids (r  0.280 and 0.237, respectively).
TABLE 6. Pearson Correlation Matrix Showing Relationships between Study Parameters, Analyzed Separately for Subjects 31 Years, between




































Subjects aged 31 years (n  195)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.966* 1
Nutrient density of dietary L 0.871* 0.943* 1
Serum L (g/mL) 0.310* 0.333* 0.313* 1
Absolute dietary Z (mg/day) 0.762* 0.687* 0.542* 0.206* 1
Energy-adjusted dietary Z 0.715* 0.735* 0.639* 0.239* 0.931* 1
Nutrient density of dietary Z 0.648* 0.702* 0.667* 0.250* 0.847* 0.951* 1
Serum Z (g/mL) 0.102* 0.134* 0.138* 0.513* 0.191* 0.210* 0.226* 1
MP optical density 0.170† 0.157* 0.153† 0.233* 0.147* 0.133† 0.233* 0.197* 1
Subjects aged 31 to 53 years (n  435)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.962* 1
Nutrient density of dietary L 0.844* 0.925* 1
Serum L (g/mL) 0.295* 0.307* 0.311* 1
Absolute dietary Z (mg/day) 0.665* 0.576* 0.469* 0.164* 1
Energy-adjusted dietary Z 0.610* 0.645* 0.607* 0.185* 0.899* 1
Nutrient density of dietary Z 0.569* 0.633* 0.701* 0.223* 0.790* 0.933* 1
Serum Z (g/mL) 0.160* 0.226* 0.144* 0.473* 0.241* 0.257* 0.253* 1
MP optical density 0.239* 0.237* 0.192* 0.237* 0.233* 0.193* 0.160* 0.137† 1
Subjects aged 53 years (n  196)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.970* 1
Nutrient density of dietary L 0.866* 0.941* 1
Serum L (g/mL) 0.260* 0.283* 0.262* 1
Absolute dietary Z (mg/day) 0.693* 0.614* 0.490* 0.247* 1
Energy-adjusted dietary Z 0.628* 0.646* 0.596* 0.293* 0.917* 1
Nutrient density of dietary Z 0.548* 0.597* 0.621* 0.294* 0.818* 0.951* 1
Serum Z (g/mL) 0.249* 0.266* 0.249* 0.563* 0.252* 0.288* 0.305* 1
MP optical density 0.189* 0.198* 0.195* 0.177† 0.198* 0.224* 0.233* 0.074‡ 1
Symbols and significances are as described in Table 4.
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FIGURE 3. Comparative representation of MP optical density, adjusted
for serum lutein concentrations, with respect to variables relevant to
risk for age-related maculopathy (ANCOVA); vertical bars: SE. Ab-
breviations are as in Figure 1.
FIGURE 4. Comparative representation of MP optical density, adjusted
for serum zeaxanthin concentrations, with respect to variables relevant
to risk for age-related maculopathy (ANCOVA); vertical bars:  SE.
Abbreviations are as in Figure 1.
TABLE 7. Pearson Correlation Matrix Showing Relationships between Study Parameters, Analyzed for Subjects with a BMI 23, with a BMI




































Subjects with BMI 23 (n  270)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.970* 1
Nutrient density of dietary L 0.834* 0.913* 1
Serum L (g/mL) 0.302* 0.325* 0.294* 1
Absolute dietary Z (mg/day) 0.781* 0.708* 0.526* 0.204* 1
Energy-adjusted dietary Z 0.734* 0.751* 0.640* 0.237* 0.930* 1
Nutrient density of dietary Z 0.664* 0.720* 0.724* 0.263* 0.814* 0.940* 1
Serum Z (g/mL) 0.151† 0.154* 0.103* 0.469* 0.209* 0.225* 0.220* 1
MP optical density 0.317* 0.278* 0.194* 0.181* 0.358* 0.309* 0.250* 0.230* 1
Subjects with BMI 23–27 (n  345)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.959* 1
Nutrient density of dietary L 0.830* 0.920* 1
Serum L (g/mL) 0.320* 0.349* 0.351* 1
Absolute dietary Z (mg/day) 0.699* 0.596* 0.463* 0.159* 1
Energy-adjusted dietary Z 0.640* 0.659* 0.598* 0.201* 0.906* 1
Nutrient density of dietary Z 0.595* 0.649* 0.695* 0.247* 0.800* 0.940* 1
Serum Z (g/mL) 0.189† 0.191† 0.164* 0.411* 0.238* 0.257* 0.253* 1
MP optical density 0.193† 0.157† 0.113† 0.198† 0.164* 0.112† 0.155† 0.194† 1
Subjects with BMI 27 (n  211)
Absolute dietary L (mg/day) 1
Energy-adjusted dietary L 0.959* 1
Nutrient density of dietary L 0.881* 0.957* 1
Serum L (g/mL) 0.171* 0.179* 0.199* 1
Absolute dietary Z (mg/day) 0.578* 0.492* 0.428* 0.11 1
Energy-adjusted dietary Z 0.513* 0.561* 0.553* 0.123 0.890* 1
Nutrient density of dietary Z 0.437* 0.502* 0.553* 0.127 0.810* 0.946* 1
Serum Z (g/mL) 0.118* 0.133* 0.185* 0.484* 0.217* 0.249* 0.273* 1
MP optical density 0.136† 0.112‡ 0.083‡ 0.165* 0.201* 0.168* 0.155* 0.082‡ 1
Symbols and significances are as described in Table 4.
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(µg/mL)
FIGURE 5. Relationship between se-
rum concentrations of zeaxanthin
(micrograms per milliliter) and MP
optical density in 615 healthy sub-
jects with no known family history of
ARM and 176 healthy subjects with a
clinically confirmed family history of
ARM. MP, macular pigment.
(µg/mL)
FIGURE 6. Relationship between se-
rum concentrations of lutein (micro-
grams per milliliter) and MP optical
density in 659 healthy subjects who
were nonsmokers, 120 healthy sub-
jects who were light current smokers
(20 cigarettes per day), and 45
healthy subjects who were heavy
current smokers (20 cigarettes per
day). MP, macular pigment.
(µg/mL)
FIGURE 7. Relationship between se-
rum concentrations of zeaxanthin
(g/mL) and MP optical density for
659 healthy subjects who were non-
smokers, 120 healthy subjects who
were light current smokers (20 cig-
arettes per day) and 45 healthy sub-
jects who were heavy current smok-
ers (20 cigarettes per day). MP,
macular pigment.
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Of note, after adjustment for confounding variables, the relation-
ships were only slightly enhanced (absolute diet L/serum L, r 
0.284 and absolute diet Z/serum Z, r  0.250).
Also, energy-adjusted (by the residuals method) and nutri-
ent density L (and Z) were positively and significantly related to
serum concentrations of their respective carotenoid, with Pear-
son correlation coefficients ranging from 0.259 to 0.303 for the
entire study group. We felt it appropriate to calculate energy-
adjusted values, as an absolute amount of a specific nutrient
tends to have less of an effect for a larger, higher energy-
consuming person, than for a smaller person. The slightly
stronger relationships we found for energy-adjusted and nutri-
ent density values most likely reflect this.
Further, the present study comprised a sample size large
enough to assess and compare, for the first time, the relation-
ships between dietary intake of L (and Z), serum concentra-
tions of L (and Z) and MP optical density, among different
groups in the normal population (e.g., males, females, subjects
with a confirmed family history of ARM, subjects with no
known family history of ARM, cigarette smokers, nonsmokers).
Of interest, subdividing according to sex, family history,
cigarette smoking, age, and BMI (putative and known risk
factors for ARM), the respective relationships between dietary
intake and serum concentrations of L (and Z) remained positive
and statistically significant, with the sole exception of the
relationship between dietary (whether absolute, energy-ad-
justed or nutrient densities) and serum levels of L for current
heavy smokers (20 cigarettes per day), who failed to exhibit
a significant relationship between these measures (Table 5).
It appears, therefore, that the risk that sex, family history of
ARM, smoking, age, and BMI represent for ARM is not attrib-
utable to impaired digestion and/or intestinal absorption of Z.
Similarly, the risk that sex, family history of ARM, age, and BMI
represent for ARM is not associated with impaired digestion or
intestinal absorption of L. However, the failure of heavy ciga-
rette smokers to exhibit the typical positive and significant
relationship between dietary intake of L and serum concentra-
tions of this carotenoid is interesting and warrants discussion.
Given that heavy cigarette smokers typically had a dietary
intake of L similar to that of light cigarette smokers and non-
smokers (P  0.05, for all), and that heavy cigarette smokers
had lower serum levels of L than did nonsmokers (even after
adjustment for dietary intake of L), indicates that heavy users of
tobacco have a compromised digestion and/or absorption of
this carotenoid or that consumption of cigarettes reduces cir-
culating levels of L.
Possible mechanisms whereby tobacco use is related to
reduced circulation of serum L and/or an impaired diet L/se-
rum L relationship requires discussion. One possibility includes
an altered lipoprotein profile in cigarette smokers, with a
consequential impact on the transport of L within serum. For
example, high-density lipoproteins (HDL) are known to be the
primary carriers of L and Z, whereas low-density lipoproteins
(LDL) transport hydrocarbon carotenoids (e.g., lycopene,
-carotene).54 Given that cigarette smokers are known to have
significantly reduced levels of HDL when compared to non-
smokers,55 it is possible that reduced HDL in tobacco users
may account for the reduced serum concentrations of L (and Z)
that we report for such individuals. Alternatively, the increased
circulating pro-oxidant load in cigarette smokers could result
in depletion of circulating levels of L (and Z). Indeed, Handel-
man et al.56 have shown that exposing human plasma to the
gas phase of cigarette smoke results in a significant depletion
(up to 60%) of L (Z) after just 9 hours’ exposure time (9
hours’ exposure time  3 puffs/h for 9 hours).
Studies investigating the relationship between retinal and
serum carotenoids should be interpreted with caution, primar-
ily because serum concentrations of L and Z reflect recent
nutritional intake only.57 In contrast, MP has a slow biological
turnover, and probably reflects the local balance between
pro-oxidant stresses and antioxidant defenses in the retina. In
other words, a dramatic change in diet is unlikely to affect MP
for several weeks, but will be reflected in much more rapid
changes in serum concentrations of L and Z.
Of the nine observational studies investigating the relation-
ship between serum L and Z and MP optical density, seven
have found positive and significant correlations (r  0.21–
0.82, P  0.05).10,12,13,15,39,42,50,58,59 Of the studies that did
not report significant relationships, one was limited by its
inclusion of only 20 subjects (10 monozygotic twin pairs)59
and the other by its narrow range of serum concentrations of
L and Z, represented by standard deviations of 0.043 g/mL
and 0.014 g/mL, respectively.58
We also found serum concentrations of L and Z to be
positive and significant predictors of MP optical density. Of
interest, controlling for age, sex, family history, cigarette smok-
ing, and absolute dietary intake of L, enhanced the strength of
the relationship between serum L and MP optical density (r 
0.232, P  0.01), whereas, the strength of the relationship
between serum Z and MP optical density was reduced after
controlling for the same variables (and replacing absolute di-
etary intake of L with that of Z; r  0.082, P  0.05).
Finally, and of noteworthy interest, subjects with a clinically
confirmed family history of ARM, current heavy cigarette smok-
ers, subjects 53 years of age, and subjects with a BMI  27,
did not exhibit a significant relationship between MP optical
density and serum concentrations of Z (r  0.041, r  0.001,
r  0.074 and r  0.082, respectively, P  0.05, for all).
Similarly, current heavy cigarette smokers did not exhibit a
positive and significant relationship between serum L and MP
optical density (r  0.042, P  0.05). For all other subgroups
(men, women, subjects with no known family history of ARM,
nonsmokers, current light smokers, subjects aged 31 years,
subjects between 31 and 52 years of age, subjects with a BMI
23, and subjects with a BMI between 23 and 27), the rela-
tionship between MP optical density and serum concentrations
of L (and Z) were positive and statistically significant.
It appears, therefore, that risk factors for ARM are associ-
ated with a lack of the typical positive and significant relation-
ship between serum concentrations of Z and MP optical den-
sity before the onset of disease. Although many of these risk
factors were associated with lower levels of Z in serum and
with lower MP optical density, it is the attenuated relationship
between these variables that is of interest, and warrants dis-
cussion. The lack of a positive and significant relationship
between serum Z and MP optical density could be attributable
to defective capture of this carotenoid by the retina and/or
impaired stabilization within the retina, in association with risk
for ARM. Certainly, high BMI could be associated with compe-
tition between the retina and adipose tissue for circulating
carotenoids, but it is difficult to explain why uptake of Z (and
not L) by the retina may be compromised in association with
other risk factors for ARM.
However, the mechanisms governing retinal capture of
carotenoids remain poorly understood, and xanthophyll-bind-
ing proteins (XBPs) are thought to be important.60 Of interest,
a zeaxanthin-binding protein (ZBP; Pi isoform of glutathione
S-transferase [GSTP1]), which is found in high concentrations
of the inner and outer plexiform layers of the macula (location
of MP),4,61 has been shown to demonstrate a high affinity for
dietary Z, with poor affinity for L.62 This finding indicates that
L and Z have unique specific binding proteins within the
macula, which are responsible for uptake and/or stabilization
of each carotenoid. It is possible, in theory at least, that some
risk factors for ARM, such as family history of ARM and age,
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could be associated with a lack of GSTP1, and thus explain our
findings.
Alternatively, however, it is possible that our finding that
risk for ARM is not associated with the typical significant and
positive relationships between MP and serum concentrations
of Z, and the relative lack of MP and serum Z seen in associa-
tion with many of these risk factors, reflects the compromised
ability of the retina to stabilize this carotenoid. For example,
there is a growing body of evidence that oxidative stress is
etiologically important in the pathogenesis of ARM, and it is
known that Z acts as an antioxidant within the retinal tissues.
It is reasonable to hypothesize, therefore, that a retina at
particularly high risk of ARM represents a high oxidative stress
environment, and would be associated with excessive deple-
tion of Z, and a consequentially reduced MP optical density and
an attenuated relationship, if any, with serum levels of this
carotenoid.
Of note, our finding that serum concentrations of Z (ad-
justed for dietary intake) were significantly reduced in associ-
ation with three established risk factors for this condition (age,
tobacco use, and BMI) in healthy young and middle-aged sub-
jects, is consistent with the finding of Gale et al.6 that ARM is
associated with a relative lack of serum Z. With respect to our
finding that heavy cigarette smokers also did not demonstrate
a positive and significant relationship between MP optical
density and serum levels of L, we offer the same explanation as
for Z.
However, the fact that MP represents a composite measure
of retinal L, Z, and meso-Z may confound any interpretation of
our findings. For example, Z dominates the central foveal
region, whereas L is typically dominant in the perifoveal re-
gion.61,63 meso-Z [(3R,3S)-,-carotene-3,3diol], a carotenoid
not found in the normal human diet, is observed to reach its
maximum concentration at the foveola, at the same point
where the L to Z ratio reaches a minimum.61,64,65 Of interest,
it has been shown that the L proportion of MP decreases with
increasing proportion of meso-Z. It has been suggested that L
undergoes a chemical oxidation in the central retina (double
bond isomerization), and is oxidized to meso-Z.5,64 Such a
conversion, within the retina, may cause changes in the ana-
tomic distribution of MP. For example, a person with large
amounts of serum L might be expected to have high peak MP
(as this is where meso-Z is found in the retina). Therefore, the
relationship between MP and each of its two constituent caro-
tenoids within serum will be influenced by the amount of L
that is converted to meso-Z at the precise retinal location
where MP optical density is being measured. However, a de-
tailed in vitro study would be needed to explore such an effect.
Of note, there is no evidence to suggest that metabolic trans-
formations involving L and Z (L to meso-Z) occur in serum.64
Consistent with this view, a recent study in which rhesus
monkeys, reared on carotenoid-free diets, were fed L or Z
reported an absence of serum Z in the L-fed group and only
trace amounts of 3didehydrolutein (a variant of L) in the Z-fed
group, suggesting that such interconversion between L and Z
in the serum is negligible.66 In any case, all in vivo techniques
that measure MP do so without distinguishing between retinal
L, Z, or meso-Z (because the optical properties are identical for
these three compounds).
In conclusion, there is no demonstrable relationship be-
tween serum levels of Z and MP optical density in heavy
cigarette smokers, subjects with a family history of ARM, older
subjects and subjects with a BMI  27, and no demonstrable
relationship between serum L and MP optical density in heavy
smokers. The finding that risk for ARM is not associated with
the typical positive and significant relationship between serum
Z and MP optical density in subjects without such risk factors,
and decades before the onset of disease, would be consistent
with compromised retinal capture and/or stabilization of this
carotenoid in maculae predisposed to ARM.
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